Clinical Trial Update: Antihyperlipidemic Effects of Oyster Mushrooms [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports a completed Phase 1/2 trial evaluating whether oyster mushrooms have antihyperlipidemic effects, sponsored by the Nationa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hyperlipidemia

Drugs mentioned

• Oyster mushroom (Pleurotus ostreatus) (Pleurotus ostreatus)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: HIV Infections, Hyperlipidemia | Phase 1, Phase 2 | Status: COMPLETED